Anticoagulant therapy is prescribed less often in paroxysmal atrial fibrillation regardless of thromboembolic risk: Results from the Registry of Atrial Fibrillation To Investigate New Guidelines (RAFTING)-Reference-Cited by-同舟云学术

Anticoagulant therapy is prescribed less often in paroxysmal atrial fibrillation regardless of thromboembolic risk: Results from the Registry of Atrial Fibrillation To Investigate New Guidelines (RAFTING)

Published:2014-08 Issue:3 Volume:175 Page:569-570
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Pipilis Athanasios,Farmakis Dimitrios,Kaliambakos Sotirios,Antoniou Anna,Goudevenos John,Lekakis John

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society;January;Circulation,2014

2. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation

3. Clinical profile and therapeutic management of patients with atrial fibrillation in Greece: results from the registry of atrial fibrillation to investigate new guidelines (RAFTING);Farmakis;Hellenic J Cardiol,2013

4. Euro Heart Survey Investigators. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation;Nieuwlaat;Eur Heart J,2006

5. GARFIELD Registry Investigators. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international observational prospective GARFIELD registry;Kakkar;PLoS ONE,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study;Kardiologia Polska;2018-05-11

2. Anticoagulation therapy in elderly patients with atrial fibrillation;Journal of Cardiovascular Medicine;2017-07

3. The treatment of paroxysmal atrial fibrillation in UK primary care;Heart;2017-06-01

4. Antikoagulationssituation bei hohem thromboembolischem Risiko nach Vorhofflimmerablation: Daten des Ablations-Qualitätsregisters;DMW - Deutsche Medizinische Wochenschrift;2014-09-16